The evolving role of biomarkers for osteoarthritis
- 7 July 2014
- journal article
- review article
- Published by SAGE Publications in Therapeutic Advances in Musculoskeletal Disease
- Vol. 6 (4) , 144-153
Abstract
Osteoarthritis (OA) is an increasingly important public health concern as the prevalence of this disease becomes higher and higher due to the ageing population. However, in addition to the absence of disease-modifying treatments, there are no sensitive diagnostic techniques beyond classical radiography, and physicians cannot predict who will progress with the disease. As a result, disease progression cannot be prevented or halted. Therefore, there is an urgent need for more effective techniques than radiography. Reliable, quantitative and dynamic tests to detect early damage and measure the progress of treatments targeted against joint destruction are required. Biomarkers, in addition to magnetic resonance imaging, are tools that can address these therapeutic shortcomings. Structural molecules and fragments derived from bone, cartilage and the synovium, all of which are affected by OA, have been reported to be potential candidates for biomarkers of OA. As the identification of biomarkers that can be applied more broadly from the very early to the end stages of knee OA is required, advances in the OA biomarker field remain challenging, but steadily progressive. Such advances will come not only from basic, but also preclinical and clinical research. In this review, we highlight recent OA biomarker studies generally published between 2011 and 2012. We classified the studies in this review into the following three categories: unique characteristics of the urinary level of C-terminal telopeptide of type II collagen; insight into the pathophysiology of OA revealed by biochemical biomarkers; and candidates for novel biomarkers of OA revealed by proteomics.Keywords
This publication has 59 references indexed in Scilit:
- The factors associated with pain severity in patients with knee osteoarthritis vary according to the radiographic disease severity: a cross-sectional studyOsteoarthritis and Cartilage, 2013
- A relationship between mechanically-induced changes in serum cartilage oligomeric matrix protein (COMP) and changes in cartilage thickness after 5 yearsOsteoarthritis and Cartilage, 2012
- Serum adipokines in osteoarthritis; comparison with controls and relationship with local parameters of synovial inflammation and cartilage damageOsteoarthritis and Cartilage, 2012
- Identification of a Panel of Novel Serum Osteoarthritis BiomarkersJournal of Proteome Research, 2011
- Temporal relationship between serum adipokines, biomarkers of bone and cartilage turnover, and cartilage volume loss in a population with clinical knee osteoarthritisArthritis & Rheumatism, 2011
- Relation of synovitis to knee pain using contrast-enhanced MRIsAnnals of the Rheumatic Diseases, 2010
- Fibulin-3 negatively regulates chondrocyte differentiationBiochemical and Biophysical Research Communications, 2010
- Reduction of cardiovascular risk factors with longterm fish oil treatment in early rheumatoid arthritis.2006
- Fibulins 3 and 5 Antagonize Tumor Angiogenesis In vivoCancer Research, 2006
- Synovitis: a potential predictive factor of structural progression of medial tibiofemoral knee osteoarthritis – results of a 1 year longitudinal arthroscopic study in 422 patientsOsteoarthritis and Cartilage, 2005